StockNews.com began coverage on shares of Nymox Pharmaceutical (NASDAQ:NYMX – Get Rating) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Nymox Pharmaceutical Stock Performance Shares of NYMX opened at $0.36 on Thursday. Nymox Pharmaceutical has a 52-week low of $0.19 and a 52-week […]
StockNews.com assumed coverage on shares of Nymox Pharmaceutical (NASDAQ:NYMX – Get Rating) in a report issued on Wednesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Nymox Pharmaceutical Stock Down 10.0 % NASDAQ NYMX opened at $0.34 on Wednesday. The stock’s 50-day moving average is $0.40 and its 200-day moving average is […]
Equities Research Analysts’ new coverage for Wednesday, March 29th: StockNews.com began coverage on shares of ATA Creativity Global (NASDAQ:AACG). StockNews.com issued a sell rating on the stock. StockNews.com assumed coverage on shares of Atlantic American (NASDAQ:AAME). The firm issued a hold rating on the stock. StockNews.com began coverage on shares of Almaden Minerals (NYSEAMERICAN:AAU) (TSE:AMM). […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Prostate cancer is the most common cancer in men and accounts for the second most cancer deaths among men globally. The rise in the number of cases of prostate cancer has led to growing government